Safer surface ablation option
Orca Surgical, developer of EBK, a new treatment procedure for surface epithelium removal, has announced positive results of a clinical study on the safety and efficacy conducted by Dr José L Güell at the IMO Center in Barcelona. Dr Güell is an associate professor of ophthalmology at the Autonoma University of Barcelona since 1991.
The study, in which Orca Surgical’s the Epi-Clearâ„¢ device was used, suggests that doctors should take into consideration treatment bed condition and risk of corneal trauma when performing surface ablation. “The Epi-Clear is an excellent device for de-epithelisation in PRK, CXL and epithelial biopsies,†says Dr Güell. “The rate of re-epithelisation is much faster than with other methods.â€
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.